Elekta AB Stock

SEK47.64

1.57% yesterday

Stockholm, Jul 21, 05:29 pm CET

ISIN

SE0000163628

Symbol

EKTA B

Index

STOXX Europe 600

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts Strategies

Elekta AB Stock price

SEK47.64

-37.30 43.92% 5Y

Stockholm, Closing price Mon, Jul 21 2025

-0.76 1.57%

ISIN

SE0000163628

Symbol

EKTA B

Index

STOXX Europe 600

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

SEK17.7b

Enterprise Value

SEK22.3b

Net debt

SEK4.6b

Cash

SEK3.0b

Shares outstanding

382.1m

Valuation (TTM | estimate)

P/E

78.1 | 11.4

P/S

1.0 | 0.9

EV/Sales

1.2 | 1.1

EV/FCF

21.1

P/B

2.0

Dividends

DPS

SEK1.20

Yield 1Y | 5Y

2.5% | 2.0%

Growth 1Y | 5Y

-50.0% | -7.7%

Payout 1Y | 3Y

35.2% | 67.4%

Increased

0 Years

Financials (TTM | estimate)

Revenue

SEK18.0b | SEK19.5b

EBITDA

SEK2.8b | SEK3.8b

EBIT

SEK2.2b | SEK2.4b

Net Income

SEK237.0m | SEK1.6b

Free Cash Flow

SEK1.1b

Growth (TTM | estimate)

Revenue

-0.6% | 8.0%

EBITDA

-3.7% | 38.9%

EBIT

-8.7% | 12.4%

Net Income

-81.8% | 587.2%

Free Cash Flow

29.3%

Financial Health

Equity Ratio

30.4%

Return on Equity

2.7%

ROCE

13.0%

ROIC

6.5%

Debt/Equity

0.9

EPS

SEK0.6

FCF per Share

SEK2.8

Short interest

Employees

Rev per Employee

SEK4.0m

As a Free StocksGuide user, you can view scores for all 7,010 stocks worldwide.

Get Started for Free Today

Elekta AB Stock Analysis

Unlock Scores for Free

??

21 Analysts have issued a Elekta AB forecast:

9x Hold

43%

9x Sell

43%

More details on Analyst Estimates Including Price Targets

21 Analysts have issued a Elekta AB forecast:

Buy

14%

Hold

43%

Sell

43%

Analyst Estimates with Stock Price Targets

Financial data from Elekta AB

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Apr '25		+/- %
Revenue	18,017 18,017	1% 1% 100%
- Direct Costs	11,205 11,205	1% 1% 62%
Gross Profit	6,812 6,812	0% 0% 38%
- Selling and Administrative Expenses	2,879 2,879	2% 2% 16%
- Research and Development Expense	1,000 1,000	20% 20% 6%
EBITDA	2,824 2,824	4% 4% 16%
- Depreciation and Amortization	663 663	18% 18% 4%
EBIT (Operating Income) EBIT	2,161 2,161	9% 9% 12%
Net Profit	237 237	82% 82% 1%

In millions SEK.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. Elekta operates through the following geographical segments: North and South America; Europe, Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

Head office	Sweden
CEO	Jonas Bolander
Employees	4,541
Founded	1972
Website	www.elekta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now